|
[1]TAKETA K.Alpha-fetoprotein:reevaluation in hepatology[J].Hepatology,1990,12(6):1420-1432.
|
|
[2]NAGAOKA S,YATSUHASHI H,HAMADA H,et al.The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma[J].Cancer,2003,98(12):2671-2677.
|
|
[3]HUNG CH,CHIU YC,CHEN CH,et al.MicroRNAs in hepatocellular carcinoma:carcinogenesis,progression,and therapeutic target[J].Biomed Res Int,2014(1),2014:486407.
|
|
[4]GUPTA S,BENT S,KOHLWES J.Test characteristics of alphafetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C.A systematic review and critical analysis[J].Ann Intern Med,2003,139(1):46-50.
|
|
[5]RICHARDSON P,DUAN Z,KRAMER J,et al.Determinants of serum alpha-fetoprotein levels in hepatitis C-infected patients[J].Clin Gastroenterol Hepatol,2012,10(4):428-433.
|
|
[6]XIAO L,ZHANG RL,ZHANG H,et al.Comparison of the clinical characteristics and survival between Uyghur patients with hepatitis virus-related and non-B,non-C hepatocellular carcinoma in Xinjiang,China[J].Chin J Cancer Res,2015,27(3):279-287.
|
|
[7]GIANNINI EG,SAMMITO G,FARINATI F,et al.Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma:implications for its clinical use[J].Cancer,2014,120(14):2150-2157.
|
|
[8]MEGURO M,MIZUGUCHI T,NISHIDATE T,et al.Prognostic roles of preoperative alpha-fetoprotein and des-gamma-carboxy prothrombin in hepatocellular carcinoma patients[J].World J Gastroenterol,2015,21(16):4933-4945.
|
|
[9]LI D,MALLORY T,SATOMURA S.AFP-L3:a new generation of tumor marker for hepatocellular carcinoma[J].Clin Chim Acta,2001,313(1-2):15-19.
|
|
[10]YI X,YU S,BAO Y.Alpha-fetoprotein-L3 in hepatocellular carcinoma:a meta-analysis[J].Clin Chim Acta,2013,425:212-220.
|
|
[11]TOYODA H,KUMADA T,TADA T,et al.Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein<20 ng/ml[J].Cancer Sci,2011,102(5):1025-1031.
|
|
[12]SATO Y,NAKATA K,KATO Y,et al.Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein[J].N Engl J Med,1993,328(25):1802-1806.
|
|
[13]TAKETA K,ENDO Y,SEKIYA C,et al.A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma[J].Cancer Res,1993,53(22):5419-5423.
|
|
[14]KOBAYASHI M,KUROIWA T,SUDA T,et al.Fucosylated fraction of alpha-fetoprotein,L3,as a useful prognostic factor in patients with hepatocellular carcinoma with special reference to low concentrations of serum alpha-fetoprotein[J].Hepatol Res,2007,37(11):914-922.
|
|
[15]ZHANG XF,YIN ZF,WANG K,et al.Changes of serum alphafetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma:prognostic significance[J].Hepatobiliary Pancreat Dis Int,2012,11(6):618-623.
|
|
[16]STENFLO J,FERNLUND P,EGAN W,et al.Vitamin K dependent modifications of glutamic acid residues in prothrombin[J].Proc Natl Acad Sci USA,1974,71(7):2730-2733.
|
|
[17]TAKEJI S,HIROOKA M,KOIZUMI Y,et al.Des-gammacarboxy prothrombin identified by P-11 and P-16 antibodies reflects prognosis for patients with hepatocellular carcinoma[J].JGastroenterol Hepatol,2013,28(4):671-677.
|
|
[18]ZHU R,YANG J,XU L,et al.Diagnostic Performance of Des-gamma-carboxy Prothrombin for Hepatocellular Carcinoma:A Meta-A-nalysis[J].Gastroenterol Res Pract,2014,2014:529314.
|
|
[19]LOK AS,STERLING RK,EVERHART JE,et al.Des-gammacarboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma[J].Gastroenterology,2010,138(2):493-502.
|
|
[20]MIYAAKI H,NAKASHIMA O,KUROGI M,et al.Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absenceⅡare potential indicators of a poor prognosis:a histopathological study of surgically resected hepatocellular carcinoma[J].J Gastroenterol,2007,42(12):962-968.
|
|
[21]KOBAYASHI M,IKEDA K,KAWAMURA Y,et al.High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma[J].Cancer,2009,115(3):571-580.
|
|
[22]MATSUBARA M,SHIRAHA H,KATAOKA J,et al.Des-gamma-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma[J].J Gastroenterol Hepatol,2012,27(10):1602-1608.
|
|
[23]MARRERO J A,FENG Z,WANG Y,et al.Alpha-fetoprotein,des-gamma carboxyprothrombin,and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma[J].Gastroenterology,2009,137(1):110-118.
|
|
[24]TANAKA T,TANIGUCHI T,SANNOMIYA K,et al.Novel desgamma-carboxy prothrombin in serum for the diagnosis of hepatocellular carcinoma[J].J Gastroenterol Hepatol,2013,28(8):1348-1355.
|
|
[25]SHARMA B,SRINIVASAN R,CHAWLA YK,et al.Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population[J].Hepatol Int,2010,4(3):569-576.
|
|
[26]ZAKHARY NI,KHODEER SM,SHAFIK HE,et al.Impact of PIVKA-II in diagnosis of hepatocellular carcinoma[J].J Adv Res,2013,4(6):539-546.
|
|
[27]MAO Y,YANG H,XU H,et al.Golgi protein 73(GOLPH2)is a valuable serum marker for hepatocellular carcinoma[J].Gut,2010,59(12):1687-1693.
|
|
[28]MARRERO JA,ROMANO PR,NIKOLAEVA O,et al.GP73,a resident Golgi glycoprotein,is a novel serum marker for hepatocellular carcinoma[J].J Hepatol,2005,43(6):1007-1012.
|
|
[29]HU JS,WU D W,LIANG S,et al.GP73,a resident Golgi glycoprotein,is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population[J].Med Oncol,2010,27(2):339-345.
|
|
[30]WANG Y,YANG H,XU H,et al.Golgi protein 73,not Glypican-3,may be a tumor marker complementary to alpha-Fetoprotein for hepatocellular carcinoma diagnosis[J].J Gastroenterol Hepatol,2014,29(3):597-602.
|
|
[31]BROKER ME,IJZERMANS JN,WITJES CD,et al.The predictive value of Golgi protein 73 in differentiating benign from malignant liver tumors[J].PLoS One,2014,9(7):e100187.
|
|
[32]HOU SC,XIAO MB,NI RZ,et al.Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma[J].Oncol Lett,2013,6(4):1152-1158.
|
|
[33]SUN Y,YANG H,MAO Y,et al.Increased Golgi protein 73 expression in hepatocellular carcinoma tissue correlates with tumor aggression but not survival[J].J Gastroenterol Hepatol,2011,26(7):1207-1212.
|
|
[34]SHAN SG,GAO YT,XU YJ,et al.Gradually increased Golgi protein 73 expression in the progression of benign liver diseases to precancerous lesions and hepatocellular carcinoma correlates with prognosis of patients[J].Hepatol Res,2013,43(11):1199-1210.
|
|
[35]DONG K,CHANG J,ZU KJ,et al.Analysis of expression of Glypican-3 and ki67 in different grade of hepatocellular carcinoma[J].China Med Herald,2015,12(29):23-26,30.(in Chinese)董坤,常静,祖可佳,等.磷脂酰肌醇蛋白聚酶3与ki67在不同分化程度肝细胞癌中的表达分析[J].中国医药导报,2015,12(29):23-26,30.
|
|
[36]LIU XF,HU ZD,LIU XC,et al.Diagnostic accuracy of serum glypican-3 for hepatocellular carcinoma:a systematic review and meta-analysis[J].Clin Biochem,2014,47(3):196-200.
|
|
[37]LIU H,LI P,ZHAI Y,et al.Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma[J].World JGastroenterol,2010,16(35):4410-4415.
|
|
[38]TANGKIJVANICH P,CHANMEE T,KOMTONG S,et al.Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers[J].J Gastroenterol Hepatol,2010,25(1):129-137.
|
|
[39]ABD EGI,MOSSALLAM GI,RADWAN NH,et al.Comparing prothrombin induced by vitamin K absence-Ⅱ(PIVKA-Ⅱ)with the oncofetal proteins glypican-3,Alpha feto protein and carcinoembryonic antigen in diagnosing hepatocellular carcinoma among Egyptian patients[J].J Egypt Natl Canc Inst,2014,26(2):79-85.
|
|
[40]GARZON R,FABBRI M,CIMMINO A,et al.MicroRNA expression and function in cancer[J].Trends Mol Med,2006,12(12):580-587.
|
|
[41]TOMIMARU Y,EGUCHI H,NAGANO H,et al.Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma[J].J Hepatol,2012,56(1):167-175.
|
|
[42]LI G,SHEN Q,LI C,et al.Identification of circulating MicroR-NAs as novel potential biomarkers for hepatocellular carcinoma detection:a systematic review and meta-analysis[J].Clin Transl Oncol,2015,17(9):684-693.
|
|
[43]YIN H,PENG X,REN P,et al.MicroRNAs as a novel class of diagnostic biomarkers in detection of hepatocellular carcinoma:a meta-analysis[J].Tumour Biol,2014,35(12):12317-12326.
|
|
[44]ZHU XM,WU LJ,XU J,et al.Let-7c microRNA expression and clinical significance in hepatocellular carcinoma[J].J Int Med Res,2011,39(6):2323-2329.
|
|
[45]ZHANG J,YANG Y,YANG T,et al.MicroRNA-22,downregulated in hepatocellular carcinoma and correlated with prognosis,suppresses cell proliferation and tumourigenicity[J].Br J Cancer,2010,103(8):1215-1220.
|
|
[46]CHOI JY,JUNG SW,KIM HY,et al.Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to totalAFP[J].World J Gastroenterol,2013,19(3):339-346.
|
|
[47]HU B,TIAN X,SUN J,et al.Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma:a meta-analysis[J].Int J Mol Sci,2013,14(12):23559-23580.
|
PDF下载 ( 1667 KB)
本文二维码
下载:
